Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

Fidia Farmaceutici s.p.a.332 enrolled

Overview

The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

332

Conditions

Knee Osteoarthritis

Interventions

HYMOVISDEVICE

Intra-articular injection

PlaceboDEVICE

Intra-Articular Injection

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Symptomatic osteoarthritis of the knee. Exclusion Criteria: * No disorders which could interfere with study required assessments.

Locations (21)

Achieve Clinical Research

Birmingham, Alabama, United States

Alabama Clinical Therapeutics

Outcomes

Primary Outcomes

Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-score

Time frame: 26 weeks

Secondary Outcomes

Patient Global Assessment

Time frame: 26 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.